Alphabet Invests in Bay Area Biotech Startup, Builds It a New Lab on Verily Campus
Verily, Alphabet’s life sciences spinoff, has invested in Bay Area biotech startup Freenome in a $65 million Series A round. Freenome’s work revolves around detecting early-stage cancer. As part of the investment, Verily constructed a new lab for the company. Freenome’s 40 employees have already moved to...